AbClon Inc (174900) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.114x

Based on the latest financial reports, AbClon Inc (174900) has a cash flow conversion efficiency ratio of -0.114x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.05 Billion ≈ $-4.10 Million USD) by net assets (₩53.07 Billion ≈ $35.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AbClon Inc market cap and net worth for the company's overall valuation and market capitalisation.

AbClon Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how AbClon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AbClon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AbClon Inc ranked by their cash flow conversion efficiency. Explore 174900 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
V Zug Holding Ag SW:VZUG	0.001x
Capital A Berhad KLSE:5099	0.123x
Springsnow Food Group Co Ltd SHG:605567	0.062x
Mitra Pinasthika Mustika Tbk JK:MPMX	0.041x
Addcn Technology Co Ltd TWO:5287	0.103x
Avjennings Ltd AU:AVJ	0.025x
ARYZTA UN.ADR 1/2 SF -02 F:YZAU	N/A
Shanghai Dragonnet Tech SHE:300245	-0.035x

Annual Cash Flow Conversion Efficiency for AbClon Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of AbClon Inc from 2015 to 2025. View current stock price of AbClon Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩60.44 Billion ≈ $40.96 Million	₩-13.83 Billion ≈ $-9.37 Million	-0.229x	+53.26%
2024-12-31	₩29.41 Billion ≈ $19.93 Million	₩-14.39 Billion ≈ $-9.75 Million	-0.490x	-40.56%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	₩-9.48 Billion ≈ $-6.43 Million	-0.348x	-70.15%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	₩-7.49 Billion ≈ $-5.08 Million	-0.205x	+54.15%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	₩-8.64 Billion ≈ $-5.86 Million	-0.446x	-131.82%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	₩-5.65 Billion ≈ $-3.83 Million	-0.193x	-1414.49%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	₩-449.88 Million ≈ $-304.88K	-0.013x	-106.40%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	₩3.71 Billion ≈ $2.52 Million	0.199x	+409.96%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	₩-1.11 Billion ≈ $-755.45K	-0.064x	-274.68%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	₩-204.92 Million ≈ $-138.87K	-0.017x	+89.66%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.165x	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$264.12 Million

₩389.74 Billion KRW

Market Cap Rank

#15523 Global

#528 in Korea

Share Price

₩19560.00

Change (1 day)

-2.93%

52-Week Range

₩15010.00 - ₩89100.00

All Time High

₩90600.00